Dual MET/EGFR therapy leads to complete response and resistance prevention in a MET-amplified gastroesophageal xenopatient cohort. (Record no. 26327935)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02193 a2200673 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250517111829.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201709s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1476-5594 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1038/onc.2016.283 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Apicella, M |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20170926 |
245 00 - TITLE STATEMENT | |
Title | Dual MET/EGFR therapy leads to complete response and resistance prevention in a MET-amplified gastroesophageal xenopatient cohort. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Oncogene |
Date of publication, distribution, etc. | 03 2017 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 1200-1210 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Journal Article |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aged, 80 and over |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Animals |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antineoplastic Combined Chemotherapy Protocols |
General subdivision | pharmacology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Apoptosis |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Biomarkers, Tumor |
General subdivision | genetics |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cell Proliferation |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cetuximab |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drug Resistance, Neoplasm |
General subdivision | genetics |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | ErbB Receptors |
General subdivision | antagonists & inhibitors |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Esophageal Neoplasms |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Esophagogastric Junction |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Gene Amplification |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Lapatinib |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Mice |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Mice, Inbred NOD |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Mice, SCID |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Phosphorylation |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Proto-Oncogene Proteins c-met |
General subdivision | antagonists & inhibitors |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Quinazolines |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Signal Transduction |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Stomach Neoplasms |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Tumor Cells, Cultured |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Xenograft Model Antitumor Assays |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Migliore, C |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Capelôa, T |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Menegon, S |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Cargnelutti, M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Degiuli, M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Sapino, A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Sottile, A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Sarotto, I |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Casorzo, L |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Cassoni, P |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | De Simone, M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Comoglio, P M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Marsoni, S |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Corso, S |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Giordano, S |
773 0# - HOST ITEM ENTRY | |
Title | Oncogene |
Related parts | vol. 36 |
-- | no. 9 |
-- | p. 1200-1210 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1038/onc.2016.283">https://doi.org/10.1038/onc.2016.283</a> |
Public note | Available from publisher's website |
No items available.